Loading clinical trials...
Loading clinical trials...
This trial is conducted in Asia, Europe, Middle East, and North America. The primary objective of the trial is to evaluate the safety of Recombinant Activated Factor VII in patients with brain contusi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT05856370 · Spinal Deformity, Spinal Degenerative Disorder, and more
NCT03819608 · Mild Traumatic Brain Injury, Post Traumatic Stress Disorder
NCT07196332 · Post-traumatic Stress Disorder
NCT06434766 · Posttraumatic Stress Disorder
NCT07129590 · Smoking Cessation, Tobacco Smoking, and more
Novo Nordisk Investigational Site
Montreal
Novo Nordisk Investigational Site
Helsinki
Novo Nordisk Investigational Site
Hanover
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions